Next-Gen Sequencing Has Significant Utility for Drug-Resistant Epilepsy

Email not displaying correctly? View it in your browser.

August 7, 2018

		PRECISION MEDICINE Next-Gen Sequencing Has Significant Utility for Drug-Resistant Epilepsy From - Diagnostic Testing & Emerging Technologies Next-generation sequencing improves definitive diagnoses for children with drug-resistant epilepsy, according to a pilot study published online… Read More

		GENETIC TESTING Compliance Perspectives: Genetic Test Labs Face Growing Risk of Medical Malpractice Liability From - G2 Compliance Advisor Compliance managers of lab involved in the $3 billion consumer-based genetic testing business need to safeguard their flank against a growing legal risk… Read More

		FOCUS ON FDA Says LOINC Coding of IVD Tests Is Voluntary, Not Mandatory From - National Intelligence Report On June 15, the FDA issued a new guidance document clarifying the rules for laboratory coding of in vitro diagnostic tests. There are four… Read More

COMPLIANCE
Where's your lab safety manual?
From - Laboratory Industry Report
Laboratory leadership should be committed to providing a safe working environment, and they should believe their employees have a right to know…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Unsubscribe | Forward to a Friend | Update Preferences